Newsletter Signup | Join Community
CLL is treated with chemotherapy, precision medicines and most recently with CAR T, now with remissions of > 8 years.
Management of Acute Myeloid Leukemia: Induction, Consolidation, Precision Medicines and Stem Cell Transplantation.
Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.
Drug resistance can occur when CML no longer responds to a TKI and there are a number of possible causes
Tibsovo approved for treatment of newly diagnosed and relapsed Acute Myeloid Leukemia with an IGH1 mutation
Bosulif superior to early generation TKI's for treatment of Chronic Myelogenous Leukemia
Gazyva improves survival and delays the CLL progression.
Blincyto prolongs survival in relapsed/refractory adult ALL and can be used in combination with other medications.
Stay Current With Leukemia Treatment Advances & Connect with Others
FDA Approves Precision Medicine Enasidenib as new Targeted Treatment for individuals with AML and IDH2 genetic mutation
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.